Adiponectin, Leptin, and Resistin Are Dysregulated in Patients Infected by SARS-CoV-2

Obesity, through adipose tissue (AT) inflammation and dysregulation, represents a critical factor for COVID-19; here, we investigated whether serum levels of adiponectin, HMW oligomers, leptin, and resistin are modulated and/or correlated with clinical and biochemical parameters of severe COVID-19 patients. This study included 62 severe COVID-19 patients; 62 age and sex-matched healthy subjects were recruited as a control group. Anthropometric and biochemical parameters were obtained and compared. Adiponectin, HMW oligomers, leptin, and resistin were analyzed by ELISA. The adiponectin oligomerization state was visualized by Western blotting. When compared to healthy subjects, total adiponectin levels were statistically lower in severe COVID-19 while, in contrast, the levels of leptin and resistin were statistically higher. Interestingly, HMW adiponectin oligomers negatively correlated with leptin and were positively associated with LUS scores. Resistin showed a positive association with IL-6, IL-2R, and KL-6. Our data strongly support that adipose tissue might play a functional role in COVID-19. Although it needs to be confirmed in larger cohorts, adiponectin HMW oligomers might represent a laboratory resource to predict patient seriousness. Whether adipokines can be integrated as a potential additional tool in the evolving landscape of biomarkers for the COVID-19 disease is still a matter of debate. Other studies are needed to understand the molecular mechanisms behind adipokine’s involvement in COVID-19.

[1]  L. Joosten,et al.  Adipocytokine plasma concentrations reflect influence of inflammation but not body mass index (BMI) on clinical outcomes of COVID‐19 patients: A prospective observational study from the Netherlands , 2022, Clinical obesity.

[2]  F. Scialò,et al.  Exploring the Role of Krebs von den Lungen-6 in Severe to Critical COVID-19 Patients , 2022, Life.

[3]  D. Okuzaki,et al.  Resistin Associated With Cytokines and Endothelial Cell Adhesion Molecules Is Related to Worse Outcome in COVID-19 , 2022, Frontiers in Immunology.

[4]  P. Puthanveetil,et al.  The Head-to-Toe Hormone: Leptin as an Extensive Modulator of Physiologic Systems , 2022, International journal of molecular sciences.

[5]  X. Terra,et al.  Resistin and IL-15 as Predictors of Invasive Mechanical Ventilation in COVID-19 Pneumonia Irrespective of the Presence of Obesity and Metabolic Syndrome , 2022, Journal of personalized medicine.

[6]  Sofi Beaula Winfred,et al.  Mechanisms contributing to adverse outcomes of COVID-19 in obesity , 2022, Molecular and Cellular Biochemistry.

[7]  Andinet B Gizaw,et al.  Overweight and obesity as risk factors for COVID-19-associated hospitalisations and death: systematic review and meta-analysis , 2022, BMJ nutrition, prevention & health.

[8]  N. D’Orazio,et al.  COVID-19 and Obesity: Overlapping of Two Pandemics , 2021, Obesity Facts.

[9]  M. Bhat,et al.  Resistin: A journey from metabolism to cancer , 2021, Translational oncology.

[10]  Prince Sebastian,et al.  COVID-19 Severity in Obesity: Leptin and Inflammatory Cytokine Interplay in the Link Between High Morbidity and Mortality , 2021, Frontiers in Immunology.

[11]  F. Scialò,et al.  SARS-CoV-2: One Year in the Pandemic. What Have We Learned, the New Vaccine Era and the Threat of SARS-CoV-2 Variants , 2021, Biomedicines.

[12]  Brad J. Wood,et al.  Remarkable vessel enlargement within lung consolidation in COVID-19 compared to AH1N1 pneumonia: A retrospective study in Italy , 2021, Heliyon.

[13]  A. De Luca,et al.  Adiponectin and Sarcopenia: A Systematic Review With Meta-Analysis , 2021, Frontiers in Endocrinology.

[14]  G. Frühbeck,et al.  Obesity as an adipose tissue dysfunction disease and a risk factor for infections – Covid-19 as a case study , 2021, European Journal of Internal Medicine.

[15]  I. Benedek,et al.  Systemic Inflammation and COVID-19 Mortality in Patients with Major Noncommunicable Diseases: Chronic Coronary Syndromes, Diabetes and Obesity , 2021, Journal of clinical medicine.

[16]  Karin de Punder,et al.  Obesity as a Risk Factor for Severe COVID-19 and Complications: A Review , 2021, Cells.

[17]  J. Patrie,et al.  Reduced adiponectin levels in patients with COVID‐19 acute respiratory failure: A case‐control study , 2021, Physiological reports.

[18]  S. Kuperberg,et al.  The Role of Obesity in the Immunopathogenesis of COVID-19 Respiratory Disease and Critical Illness , 2021, American journal of respiratory cell and molecular biology.

[19]  J. Miller,et al.  Acute Symptoms of Mild to Moderate COVID-19 Are Highly Heterogeneous Across Individuals and Over Time , 2021, Open forum infectious diseases.

[20]  P. Sbraccia,et al.  Susceptibility and Severity of Viral Infections in Obesity: Lessons from Influenza to COVID-19. Does Leptin Play a Role? , 2021, International journal of molecular sciences.

[21]  U. P. Flato,et al.  Adipokines, Myokines, and Hepatokines: Crosstalk and Metabolic Repercussions , 2021, International journal of molecular sciences.

[22]  P. Lai 2019 (COVID‐19) and 2021 , 2021, Surgical practice.

[23]  Beizhong Liu,et al.  Leptin correlates with monocytes activation and severe condition in COVID-19 patients , 2021, Journal of leukocyte biology.

[24]  W. Koh,et al.  Adipokines and the risk of active TB: a nested case-control study. , 2021, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[25]  F. Scialò,et al.  Adiponectin is Associated with Neutrophils to Lymphocyte Ratio in Patients with Chronic Obstructive Pulmonary Disease , 2020, COPD.

[26]  F. Scialò,et al.  Metabolic Perturbations and Severe COVID-19 Disease: Implication of Molecular Pathways , 2020, International journal of endocrinology.

[27]  Thi Mong Diep Nguyen Adiponectin: Role in Physiology and Pathophysiology , 2020, International journal of preventive medicine.

[28]  M. van Meurs,et al.  Leptin levels in SARS-CoV-2 infection related respiratory failure: A cross-sectional study and a pathophysiological framework on the role of fat tissue , 2020, Heliyon.

[29]  A. Malavazos,et al.  COVID‐19 Rise in Younger Adults with Obesity: Visceral Adiposity Can Predict the Risk , 2020, Obesity.

[30]  M. Matera,et al.  Implications of the Adiponectin System in Non-Small Cell Lung Cancer Patients: A Case-Control Study , 2020, Biomolecules.

[31]  F. Perrotta,et al.  COVID-19 and coagulative axis: review of emerging aspects in a novel disease. , 2020, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[32]  Eun Ji Kim,et al.  Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. , 2020, JAMA.

[33]  H. Wunsch,et al.  Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19) , 2020, Critical care medicine.

[34]  E. Hoffman,et al.  Associations of Serum Adipokines with Subclinical Interstitial Lung Disease Among Community-Dwelling Adults: the MESA study. , 2019, Chest.

[35]  M. Caraglia,et al.  The anti-proliferative effects of adiponectin on human lung adenocarcinoma A549 cells and oxidative stress involvement. , 2019, Pulmonary pharmacology & therapeutics.

[36]  M. Matera,et al.  The burden of obesity in asthma and COPD: Role of adiponectin. , 2017, Pulmonary pharmacology & therapeutics.

[37]  G. E. Carpagnano,et al.  Evaluation of adiponectin profile in Italian patients affected by obstructive sleep apnea syndrome. , 2016, Pulmonary pharmacology & therapeutics.

[38]  C. Costagliola,et al.  New Insight into Adiponectin Role in Obesity and Obesity-Related Diseases , 2014, BioMed research international.

[39]  T. Tsao Assembly of adiponectin oligomers , 2014, Reviews in Endocrine and Metabolic Disorders.

[40]  Kazuto Nakamura,et al.  Adipokines: a link between obesity and cardiovascular disease. , 2014, Journal of cardiology.

[41]  Kazuto Nakamura,et al.  Adiponectin Attenuates Lipopolysaccharide-Induced Acute Lung Injury through Suppression of Endothelial Cell Activation , 2012, The Journal of Immunology.

[42]  K. Vuolteenaho,et al.  Adipokine resistin predicts anti-inflammatory effect of glucocorticoids in asthma , 2011, Journal of Inflammation.

[43]  E. Hoffman,et al.  Associations of Serum Adipokines With Subclinical Interstitial Lung Disease Among Community-Dwelling Adults The Multi-Ethnic Study of Atherosclerosis (MESA) , 2020 .

[44]  Limin Peng,et al.  Resistin is elevated in cystic fibrosis sputum and correlates negatively with lung function. , 2019, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.